Literature DB >> 24758569

Analysis of Spanish generic medicines retail market: recommendations to enhance long-term sustainability.

Pieter Dylst1, Arnold G Vulto, Steven Simoens.   

Abstract

The use of generic medicines in Spain is traditionally low compared to other European countries, despite efforts of the Spanish government in the past. This paper provides a perspective on the Spanish generic medicines retail market and how the current policy environment may affect the long-term sustainability. The Spanish government's focus on prices of generic medicines (e.g., mandatory price cuts, reference price set at the lowest level) have made them amongst the lowest in Europe. In our opinion, this combination of continuous pressure on prices and limited diffusion of generic medicines may undermine the long-term sustainability of the Spanish generic medicines retail market. The unique experience in Spain shows the impact of demand-side policies on the use of generic medicines. Because a sustainable generic medicines retail market is important to maintain future competition in the off-patent medicines market, this perspective paper rounds off with recommendations to increase its sustainability.

Keywords:  Spain; demand-side policies; generic medicines; pharmaceuticals; pricing; reimbursement; sustainability

Mesh:

Substances:

Year:  2014        PMID: 24758569     DOI: 10.1586/14737167.2014.891442

Source DB:  PubMed          Journal:  Expert Rev Pharmacoecon Outcomes Res        ISSN: 1473-7167            Impact factor:   2.217


  4 in total

1.  Policies for biosimilar uptake in Europe: An overview.

Authors:  Evelien Moorkens; Arnold G Vulto; Isabelle Huys; Pieter Dylst; Brian Godman; Simon Keuerleber; Barbara Claus; Maria Dimitrova; Guenka Petrova; Ljiljana Sović-Brkičić; Juraj Slabý; Robin Šebesta; Ott Laius; Allan Karr; Morgane Beck; Jaana E Martikainen; Gisbert W Selke; Susan Spillane; Laura McCullagh; Gianluca Trifirò; Patricia Vella Bonanno; Asbjørn Mack; Antra Fogele; Anita Viksna; Magdalena Władysiuk; Helder Mota-Filipe; Dmitry Meshkov; Marija Kalaba; Simona Mencej Bedrač; Jurij Fürst; Corrine Zara; Peter Skiöld; Einar Magnússon; Steven Simoens
Journal:  PLoS One       Date:  2017-12-28       Impact factor: 3.240

2.  Cost of treatment of peripheral neuropathic pain with pregabalin or gabapentin in routine clinical practice: impact of their loss of exclusivity.

Authors:  Antoni Sicras-Mainar; Javier Rejas-Gutiérrez; María Pérez-Páramo; Ruth Navarro-Artieda
Journal:  J Eval Clin Pract       Date:  2016-09-27       Impact factor: 2.431

Review 3.  Policies and Practices Catalyzing the Use of Generic Medicines: A Systematic Search and Review.

Authors:  Shahmoradi Mostafa; Mosadeghrad Ali Mohammad; Jaafaripooyan Ebrahim
Journal:  Ethiop J Health Sci       Date:  2021-01

4.  Analysis of the Korean generic medicine market: Factors affecting the market share of generic medicines.

Authors:  Dong-Sook Kim; Jihye Shin; Jusun Chung
Journal:  Clin Transl Sci       Date:  2021-09-29       Impact factor: 4.689

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.